Potential health benefits from coffee consumption
DOI:
https://doi.org/10.12775/JEHS.2022.12.10.001Keywords
coffee, CVD, cardiovascular, diabetes, alzheimer, caffeineAbstract
The history of coffee goes back to the 10th century. Currently, coffee is a widespread drink, with recent studies reporting a global consumption of 164,9 million 60-kg bags in 2020/2021. The effect of coffee on human health has been studied for many years. The active ingredients of coffee include polyphenols, lactones, diterpenes, niacin, the trigonelline (vitamin B3 precursor), magnesium and potassium. Potential factors that could change its properties include the type of beans, the roasting process, the grinding process and the brewing process. Authors searched PubMed and Google Scholar using searchterms coffee, cardiovascular system disease, CVD, type II diabetes, Alzheimer’s disease and caffeine. We manually searched the references of selected articles for additional relevant articles. We selected articles relevant to a general medicine readership, prioritizing systematic reviews, cases and clinical practice guidelines. The literature contains the latest reports on the impact of coffee on human health, including cardiovascular diseases, type II diabetes and Alzheimer’s disease. Drinking coffee may reduce the risk of cardiovascular disease, because of the caffeine blocking A1 and A2A receptors. It may also contribute to decreasing the risk of type II diabetes, increasing the secretion of GLP-1 and increasing the sensitivity of tissues to insulin. The influence of coffee on the development of Alzheimer’s disease is still being investigated. Coffee is a common drink for many people, so you should know its impact on human health. Contrary to appearances, coffee may have many health-promoting properties.
References
Smith RF. A History of Coffee. Coffee. 1985;1–12.
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024.
International Coffee Organization. Coffee Trade Statistics; International Coffee Organization: London, UK, 2020.
Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas. 2013;75(1):7–21.
Gómez-Ruiz JÁ, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007;55(17):6962–9.
Gloess AN, Schönbächler B, Klopprogge B, D’Ambrosio L, Chatelain K, Bongartz A, Strittmatter A, Rast M, Yeretzian C. Comparison of nine common coffee extraction methods: Instrumental and sensory analysis. Eur Food Res Technol. 2013;236(4):607–27.
Higdon J V., Frei B. Coffee and health: A review of recent human research. Crit Rev Food Sci Nutr. 2006;46(2):101–23.
Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: A systematic review and dose-response meta-Analysis. BMJ Open. 2017;7(5).
Gökcen BB, Şanlier N. Coffee consumption and disease correlations. Crit Rev Food Sci Nutr. 2019;59(2):336–48.
O’Keefe JH, DiNicolantonio JJ, Lavie CJ. Coffee for Cardioprotection and Longevity. Prog Cardiovasc Dis. 2018;61(1):38–42.
Socała K, Szopa A, Serefko A, Poleszak E, Wlaź P. Neuroprotective effects of coffee bioactive compounds: A review. Int J Mol Sci. 2021;22(1):1–64.
Nieber K. The Impact of Coffee on Health Author Pharmacokinetics and Mode of Action Bioactive Components in Coffee. Planta Med. 2017;83(1):1256–63.
de Melo Pereira G V., de Carvalho Neto DP, Magalhães Júnior AI, do Prado FG, Pagnoncelli MGB, Karp SG, Soccol CR. Chemical composition and health properties of coffee and coffee by-products. 1st ed. Vol. 91, Advances in Food and Nutrition Research. Elsevier Inc.; 2020. 65–96 p.
Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis. 2006;27(2):269–77.
Mancini RS, Wang Y, Weaver DF. Phenylindanes in brewed coffee inhibit amyloid-beta and tau aggregation. Front Neurosci. 2018;12(OCT):1–14.
de Melo Pereira G V., de Carvalho Neto DP, Magalhães Júnior AI, Vásquez ZS, Medeiros ABP, Vandenberghe LPS, Soccol CR. Exploring the impacts of postharvest processing on the aroma formation of coffee beans – A review. Food Chem. 2019;272:441–52.
Jeszka-Skowron M, Zgoła-Grześkowiak A, Grześkowiak T. Analytical methods applied for the characterization and the determination of bioactive compounds in coffee. Eur Food Res Technol. 2015;240(1):19–31.
Ludwig, Iziar A, Clifford MN, Lean MEJ, Ashiharad H, Crozier A. Coffee: biochemistry and potential impact on health. Food Funct. 2014;5:1695–1717.
Paul O, Lepper MH, Phelan WH, Dupertuis GW, Macmillan A, McKean H, Park H. A longitudinal study of coronary heart disease. Circulation. 1963;28(July):20–31.
Dobmeyer DJ, Stine RA, Leier C V., Greenberg R, Schaal SF. The arrhytmogenic effecs of caffeine in human beings. N Engl J Med. 1983;814–6.
Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG OJ. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978 Jan 26;298(4):181-6. N Engl J Med. 1978;298(4):181–6.
Thelle DS, Heyden S, Fodor JG. Coffee and cholesterol in epidemiological and experimental studies. Atherosclerosis. 1987;67(2–3):97–103.
Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. The New England Journal of Medicine on October 5, 2013. From the NEJM Archive. Massachusetts Medical Society. N Engl J Med. 1989;(320):915–24.
Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G. The New England Journal of Medicine. UC SHARED JOURNAL COLLECTION on February 14, 2011. N Engl J Med. 1993;329(20):1442–8.
Coffe drinking and acute myocardial infraction. Report from the Boston Collaborative Drug Surveillance Program. Lancet. 1972;300(7790):1278–81.
Jick H, Miettinen OS, Neff RK, Shapiro S, Heinonen OP, Slone D. Coffee and myocardial infraction. N Engl J Med. 1972;289(2):63–7.
Greenland S. A Meta-analysis of Coffee, Myocardial Infarction, and Coronary Death. Epidemiology. 1993;4(4):366–74.
Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Heart. 1994;72(3):269–75.
Sofi F, Conti AA, Gori AM, Eliana Luisi ML, Casini A, Abbate R, Gensini GF. Coffee consumption and risk of coronary heart disease: A meta-analysis. Nutr Metab Cardiovasc Dis. 2007;17(3):209–23.
Mostofsky E, Rice MS, Levitan EB, Mitlleman MA. Habitual Coffee Consumption and Risk of Heart Failure: A Dose– Response Meta-Analysis. Nat Rev Cancer. 2011;12(4):237–251.
Larsson SC, Orsini N. Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies. Am J Epidemiol. 2011;174(9):993–1001.
Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, La Vecchia C, Tavani A. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28(7):527–39.
Liu QP, Wu YF, Cheng HY, Xia T, Ding H, Wang H, Wang ZM, Xu Y. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies. Nutrition. 2016;32(6):628–36.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response MetaAnalysis of Prospective Cohort Studies. Circulation. 2014;129(6):643–59.
Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001;53(4):527–52.
Jacobson KA. Introduction to adenosine receptors as therapeutic targets. Handb Exp Pharmacol. 2009;193(193):1–24.
Godos J, Pluchinotta FR, Marventano S, Buscemi S, Volti GL, Galvano F, Grosso G. Coffee components and cardiovascular risk: Beneficial and detrimental effects. Int J Food Sci Nutr. 2014;65(8):925–36.
Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: A meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153(4):353–62.
Alzheimer Association. 2018 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2018;14(3):367–429.
Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G. Caffeine synergizes with another coffee component to increase plasma GCSF: Linkage to cognitive benefits in Alzheimer’s mice. J Alzheimer’s Dis. 2011;25(2):323–35.
Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience. 2006;142(4):941–52.
Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H. Caffeine suppresses amyloid-β levels in plasma and brain of alzheimer’s disease transgenic mice. J Alzheimer’s Dis. 2009;17(3):681–97.
Wu L, Sun D, He Y. Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies. Clin Nutr. 2017;36(3):730–6.
Larsson SC, Orsini N. Coffee consumption and risk of dementia and alzheimer’s disease: A dose-response meta-analysis of prospective studies. Nutrients. 2018;10(10).
Van Dam RM. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab. 2008;33(6):1269–83.
Ding M, Bhupathiraju SN, Chen M, Van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematicreview and a dose-response meta-analysis. Diabetes Care. 2014;37(2):569–86.
Doo T, Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G. Coffee Intake and Risk of Type 2 Diabetes: The Multiethnic Cohort. Public Heal Nutr. 2014;17(6):1328–36.
Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R, Boeing H. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr. 2012;95(4):901–8.
Loopstra-Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia. 2011;54(2):320–8.
Yarmolinsky J, Mueller NT, Duncan BB, Del Carmen Bisi Molina M, Goulart AC, Schmidt MI. Coffee consumption, newly diagnosed diabetes, and other alterations in glucose homeostasis: A cross-sectional analysis of the Longitudinal Study of Adult Health (ELSA-Brasil). PLoS One. 2015;10(5):1–15.
Ong KW, Hsu A, Tan BKH. Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: A contributor to the beneficial effects of coffee on diabetes. PLoS One. 2012;7(3).
Fujii Y, Osaki N, Hase T, Shimotoyodome A. Ingestion of coffee polyphenols increases postprandial release of the active glucagon-like peptide-1 (GLP-1(7-36)) amide in C57BL/6J mice. J Nutr Sci. 2015;4:1–9.
Rustenbeck I, Lier-Glaubitz V, Willenborg M, Eggert F, Engelhardt U, Jörns A. Effect of chronic coffee consumption on weight gain and glycaemia in a mouse model of obesity and type 2 diabetes. Nutr Diabetes. 2014;4:1–9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Michał Perszke, Dominika Egierska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1197
Number of citations: 0
